Experiments were designed to examine the effect of oxidized low density lipoproteins (Ox-LDLs) on the expression and the release of endothelin from cultured endothelial cells and intact blood vessels. Ox-LDLs (30-300 jtg/ml), but not native low density lipoproteins (200 ,ug/ml), stimulated the expression of preproendothelin mRNA in porcine and human endothelial cells, leading to a time-and concentrationdependent release of the peptide into the culture medium. The Ox-LDL-stimulated release of endothelin was mimicked by acetylated low density lipoprotein and abolished by downregulation of protein kinase C by phorbol ester. In the intact porcine aorta, Ox-LDLs, but not native low density lipoproteins, also increased the release of peptide in an endothelium-and concentration-dependent manner. The maximal effect was observed at a concentration of 100 ,g/ml. Incubation of the intact porcine aorta with the scavenger receptor antagonist dextran sulfate decreased the formation of endothelin evoked by Ox-LDLs. The Ox-LDL-stimulated production of the peptide was further augmented in the presence of thrombin (4 units/ml) and was unaffected by nitric oxide-generating compound 3-morpholinosydnonimine (10`M).
T he endothelium participates in the regulation of vascular tone by releasing relaxing factors, such as nitric oxide, or contracting substances, such as the peptide endothelin.,2 Endothelial cells are primary targets for cardiovascular risk factors such as low density lipoproteins (LDLs).3,4 Plasma LDLs can be oxidatively modified by the cells of the blood vessel wall,4-6 and oxidized LDLs (Ox-LDLs) have been found to accumulate in early plaques and atherosclerotic vascular lesions, where they may profoundly affect the endothelial function. [7] [8] [9] [10] Atherosclerotic arteries are more prone to vasospastic events than are normal blood vessels.11-'3 One feature of this disease is the impairment of the relaxations mediated by the endothelium.1214-16 This endothelial dysfunction16-20 appears to be partially due to the inhibition of the formation of nitric oxide by Ox-LDL, which accumulates within human atherosclerotic plaques.4-6 However, an enhanced production of the potent vasoconstrictor peptide endothelin2 could also participate, particularly since nitric oxide inhibits its release from intact blood vessels.21 Indeed, the circulating levels of endothelin are increased in patients with hyperlipidemia or atherosclerosis.22 '23 Hence 
Preparation of LDLs
LDLs were isolated from human plasma collected in EDTA (10`M) and butylated hydroxytoluene (BHT, 10`M) using sequential ultracentrifugation with density adjustments by potassium bromide. 26 The isolated LDLs were dialyzed against phosphate-buffered saline (PBS) in the presence of EDTA and BHT and then sterilized by filtration (filter pore size, 0.45 ,um; Gelman Sciences Inc., Ann Arbor, Mich.). Protein concentration was determined as described using bovine serum albumin as a standard.27 LDL samples were stored at 4°C in the dark and used within 2 weeks. LDLs prepared under these conditions are referred to as Nat-LDLs.
Before oxidation, LDLs were dialyzed against PBS to remove EDTA and BHT. Then they were oxidized at a concentration of 200 ,ug/ml by exposure to 
Measurement of Endothelin
Confluent and quiescent endothelial cells were incubated in 1 ml RPMI 1640 supplemented with 0.2% bovine serum albumin and exposed to Ox-LDLs, AcLDLs (Biomedical Technologies Inc., Stoughton, Mass.), or Nat-LDLs for up to 24 hours. The incubation medium was centrifuged at 250g to remove nonadherent cells and was used for the determination of endothelin by radioimmunoassay (Peninsula Laboratories, Merseyside, UK). The detection limit of the assay was 1 pg, and cross-reactivity of the antibody was 100% for endothelin-1 (porcine, human), 7% for endothelin-2 and -3, and 35% for big endothelin (porcine, human).
Intact porcine aortas with endothelium (10-cm2 intimal surface) were incubated at 37°C in 3 ml control solution containing 0.1% bovine serum albumin and aerated with a mixture of 95% 02-5% CO2 as previously reported.21 Endothelin was determined by radioimmunoassay in the incubation medium as described above. Previous work has shown that the release of endothelin from intact porcine aorta was endothelium 
Results

Expression of Endothelin mRNA
Ox-LDLs (100 gg/ml) increased endothelin transcription both in PAECs (Figure 1 , top panel) and in HAECs (Figure 1, bottom panel) . In PAECs, the increase in mRNA expression could already be observed after 2 hours and was maintained for the following 6 hours of stimulation (Figure 1 ). In IAECs, the effect of Ox-LDLs (100 gig/ml) was detected after 3 hours of stimulation, with a maximum after 4 hours (Figure 1 ). In contrast, Nat-LDLs (200 gg/ml) failed to stimulate preproendothelin mRNA within a comparable time period, both in PAECs and HAECs (Figure 1 ).
Release of Endothelin From Cultured Endothelial Cells
Ox-LDLs stimulated the release of endothelin from PAECs as compared with control conditions ( Figure  2A ). This effect was concentration dependent in the range of 30-300 ,ug/ml; concentrations lower than 30 gg/ml (data not shown) did not augment the release of the peptide as compared with that occurring in unstimulated cells. The effect of Ox-LDLs was also time dependent (0-24 hours); after 24 hours, the production rate of the peptide was similar in stimulated and control cells ( 
Release of Endothelin From Intact Blood Vessels
In the intact porcine aorta with endothelium, OxLDLs induced a concentration-dependent release of endothelin, with a maximal effect at 100 ,g/ml after 5 hours of incubation (:2.7-fold increase, Figure 3A) . Cellular Mechanism ofAction Scavenger receptor. In cultured PAECs, the effect induced by Ox-LDLs was also mimicked by Ac-LDLs (30 ,ug/ml) but not by Nat-LDLs (200 ,ug/ml, in the presence of 10-5 M BHT) ( Figure 2B ). As in cultured endothelial cells, Nat-LDLs (200 ,g/ml, with 10-5 M BHT) did not increase the release of endothelin from intact porcine aorta (control cells, 30±3 pg/cm2; NatLDLs, 26±6 pg/cm2; n=5). Incubation of intact porcine aorta with the scavenger receptor antagonist dextran sulfate (40 ug/ml; molecular weight, 500,000) prevented the release of endothelin induced by Ox-LDLs (100 1£g/ml) ( Figure 3B Effect of nitric oxide. When tissues were exposed simultaneously to maximal concentrations of Ox-LDLs (100 ,g/ml) and thrombin (4 units/ml),34 their effects on the release of endothelin from intact porcine aorta were additive ( Figure 4A ). As previously reported,37 the thrombin-induced release of the peptide was inhibited by SIN-1 (10`M), a nitric oxide-generating compound ( Figure 4B ). In contrast, the release of endothelin evoked by Ox-LDLs (100 ,g/ml) was not affected by SIN-1 (10-5 M) ( Figure 4B ). Incubation of endothelial cells for 5 hours with Ox-LDLs (100 gg/ml) did not alter the 83-fold increase of intracellular cGMP evoked by SIN-1 (10-5 M) (control cells, 1 '23 The present study demonstrates that Ox-LDLs, but not Nat-LDLs, stimulate the expression and the release of endothelin from cultured and native endothelial cells of intact blood vessels. Therefore, it provides evidence for Ox-LDL as a potential endogenous mediator of the increased release of endothelin in hyperlipidemia and atherosclerotic diseases. The stimulation of the expression of endothelin mRNA and the subsequent release of the peptide were observed both in PAECs and HAECs, emphasizing the importance of these results in humans.
The release of endothelin induced by Ox-LDL most likely involves activation of the endothelial scavenger receptor.38 41 Indeed, the production of the peptide induced by Ox-LDL could be reproduced by Ac-LDL, another ligand of the scavenger receptor,38-41 whereas Nat-LDL, which interacts with its specific receptor,42 failed to stimulate the release of endothelin. The involvement of the scavenger receptor in the effect of Ox-LDL is further supported by the fact that the scavenger receptor antagonist dextran sulfate28 totally abolished the release of endothelin induced by Ox-LDL, whereas the substance by itself was without effect. Activation of the endothelial scavenger receptor by Ox-LDL has also been involved in the inhibition of the release of endothelium-derived nitric oxide by Ox-LDL in intact porcine coronary arteries. '7,18 The effects of Ox-LDL are unlikely to be influenced by the presence of endotoxin contaminating the preparations of Ox-LDLs, since the lipoproteins were prepared under sterile conditions and because a high concentration of lipopolysaccharide did not stimulate the release of endothelin from cultured cells. Indeed, the stimulating effect of endotoxin on the release of endothelin from cultured endothelial cells requires the presence of serum. 43 Both the basal production of endothelin and that stimulated by Ox-LDL must involve activation of protein kinase C in endothelial cells, since they were markedly reduced by downregulation of the enzyme by phorbol ester. In this regard, Ox-LDL shares a similar pathway with other agonists releasing endothelin, such as angiotensin II in cultured vascular smooth muscle cells and thrombin in cultured endothelial cells. 31"44 The production of endothelin is regulated both by activating and inhibitory mechanisms. Indeed, previous work has shown that the thrombin-induced release of the peptide in the intact porcine aorta is reduced by the concomitant production of endothelium-derived nitric oxide34 as well as by exogenous nitric oxide-generating compounds such as SIN-1 or nitroglycerin.37,45 In contrast to thrombin, however, the release of endothelin evoked by Ox An increased production of the peptide may have important vascular effects. Indeed, the peptide causes potent and protracted contractions in most blood vessels.2'48,49 In addition, threshold and low concentrations of endothelin potentiate the contraction induced by norepinephrine or serotonin in human blood vessels.50 This may be of particular importance at sites of platelet activation with release of serotonin50 and thromboxane A2.51-52 Other substances formed or released under these conditions, such as thrombin and transforming growth factor-,l,53,54 would further augment the production of endothelin already increased by Ox-LDLs. Indeed, the stimulatory effect of thrombin on vascular endothelin production (which may be particularly relevant in myocardial infarction55) was fully maintained even in the presence of Ox-LDLs. Hence, locally increased levels of endothelin may upregulate the responsiveness of the blood vessel wall to vasoconstrictor stimuli and may explain that vasospastic events preferentially occur at the site of early atherosclerotic lesions.11-13,56 Inhibition of the release of endotheliumderived relaxing factor by Ox-LDLs17 may also contribute to vasospastic events, since a locally decreased production of nitric oxide would further augment endothelin production34 as well as increase the sensitivity of blood vessel to vasoconstrictor stimuli. The Ox-LDL-stimulated release of endothelin may be of particular relevance in aging, which is accompanied by accumulation of oxidized proteins,57 increase plasma levels of endothelin,58 and vascular hyperreactivity. 59 In addition to inducing vasoconstriction, endothelin may facilitate local proliferation of the vascular smooth muscle cells. The peptide evokes intracellular events known to be linked to proliferative responses such as alkalinization and expression of c-fos and c-myc protooncogenes in cultured vascular smooth muscle and mesangial cells.60-62 Endothelin also stimulates the production of autocrine growth factors by increasing the expression of platelet-derived growth factor mRNA transcript in vascular smooth muscle cells. 31 Thus, the release of endothelin from the intact endothelium induced by Ox-LDLs trapped in the vessel wall may contribute to the formation of advanced atherosclerotic lesions containing proliferative smooth muscle cells (i.e., the fibrous cape). An increased release of endothelin induced by Ox-LDLs could also explain why proliferation at sites in atherosclerotic lesions where the endothelium remains intact.3
